Fulvestrant Injection and Hepatic dysfunction
Result of checking the interaction of drug Fulvestrant Injection and disease Hepatic dysfunction for safety when used together.
When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.
Consumer:Fulvestrant is metabolized primarily in the liver. A dose of fulvestrant 250 mg is recommended in patients with moderate hepatic impairment (Child-Pugh class B). Care is recommended when using fulvestrant in patients with severe hepatic impairment (Child-Pugh class C) as the agent has not been studied in these patients.
Generic Name: fulvestrant
Brand Name: Faslodex
Synonyms: Fulvestrant